The largest database of trusted experimental protocols

Spss software 25

Manufactured by IBM
Sourced in United States

SPSS software 25.0 is a comprehensive statistical analysis tool developed by IBM. It provides a wide range of analytical capabilities for data management, statistical modeling, and reporting. The software is designed to help users extract meaningful insights from complex data sets, supporting decision-making and research across various industries and domains.

Automatically generated - may contain errors

104 protocols using spss software 25

1

Prostatic Urethral Measurements Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Values were shown as mean ± standard deviation. Two independent-samples t-tests or Mann-Whitney U test were used to compare the parameters of PV <80 mL group and PV >80 mL group as well as 2-D measurements and 3D measurements. All parameters of proximal prostatic urethra and distal prostatic urethra were compared by the paired t-test or Wilcoxon Rank-Sum test. Comparisons between age groups were made by one-way ANOVA or Kruskall-Wallis test. All statistical methods were chosen according to whether the data conformed to normal distribution. All statistical analysis was analyzed by SPSS software 25.0 (IBM, Armonk, NY, USA). P<0.05 considered statistically significant.
+ Open protocol
+ Expand
2

Propensity Score-Weighted Survival Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses of the data were performed by using the R software 4.1.0 (R Foundation for Statistical Computing, Vienna, Austria) and the SPSS software 25.0 (IBM Corporation, Armonk, NY, USA). The continuous variables were represented by a median or average depending on the normal distribution and were analyzed by using the independent t-test or the Mann–Whitney U-test. The categorical variables were represented by the frequency and its percentage of the total and were analyzed by using the Chi-square test. To make this study closely resemble a randomized clinical trial setting, the method of the PS-IPTW was employed. Multivariable logistic regression was applied to all the baseline and pathological features between the TLG and LAG groups to generate a propensity score. And using the stabilized weights to reduce variability in IPTW models. With the goal of balancing observable characteristics, each patient was weighted by the inverse probability of being in TLG vs. LAG. The univariate and multivariate Cox proportional hazards regression model was used to analyze the independent risk factors of recurrence and mortality. The Kaplan–Meier technique and the log-rank test were used to create survival curves. Statistical significance was set at p < 0.05.
+ Open protocol
+ Expand
3

Comparative Analysis of Treatment Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data will be analysed using IBM SPSS Software 25.0 (SPSS Inc. Chicago, United States). Note that any missing data will be managed by adopting the intention‐to‐treat analysis concept. The continuous variables will be checked for normality prior to analysis. The value of p < 0.05 is set as the alpha level of significance. Baseline data will be outlined with descriptive analysis. For continuous variables, mean, standard deviation, median, and range will be used; frequency and percentage will be used for categorical variables. For the comparison of categorical data between groups, the chi‐square test will be used to compare the differences between the two groups. As for continuous data, an independent sample t‐test will be used. For the primary and secondary interests of analysis, multivariable regression model analysis will be employed to adjust confounding factors in the statistical effect. In addition, Cochran’s Q test will be used to assess the changes in categorical data in both groups over time. In contrast, continuous variables that change over time will be identified using one‐way repeated measures (ANOVA). After testing for assumptions and outliers, between-groups (intervention vs control), the main effect and interaction between and within the two groups over time will be tested using generalised estimating equations.
+ Open protocol
+ Expand
4

Survival Analysis of Neoadjuvant Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The differences between the variable groups were analyzed with the Pearson's chi-squared test or Student's t-test. The interval between neoadjuvant therapy and surgery was dichotomized for OS before the log rank test by using optimal cutoff values determined by the “surv_cutpoint” function of the “survminer” R package. The survival-analyses were performed using the Kaplan–Meier method with the log rank test. Multivariate analysis were examined by the Cox proportional hazards model. Statistical analysis were performed with R software 3.6.2 and the SPSS software 25.0 (IBM Corporation, Armonk, NY, USA). P-value <0.05 was considered statistically significant.
+ Open protocol
+ Expand
5

Statistical Analysis of Continuous and Categorical Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive summaries of continuous measurements are reported as median and interquartile ranges; descriptive summaries of categorical measurements are reported as frequencies and proportions. All analyses were conducted on an intention-to-treat principle. Baseline continuous and categorical variables were assessed between groups using the Mann–Whitney U test and Fisher exact test, respectively. The Wilcoxon signed-rank test was used to analyze within-group changes from baseline and analysis of variance for placebo-corrected changes from baseline. Unadjusted P values are reported throughout, with statistical significance set at the two-tailed 0.05 level. The SPSS software 25.0 (IBM, New York, NY) was used for all analyses.
+ Open protocol
+ Expand
6

Statistical Analysis of Predictive Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses were performed by SPSS software 25.0 (IBM Corp., Armonk, NY, USA) and Python 2.7 (Python Software Foundation, Beaverton, OR, USA). Quantitative data with normal distribution were expressed as means ± standard deviations, whereas quantitative data with non-normal distribution were expressed as medians± interquartile intervals. Simultaneously, classification variables were expressed as numbers and percentages. Chi-square test, two independent sample Student’s t-test, and Mann–Whitney U-test were used for univariate analysis. The DeLong test was conducted to compare the AUC of the three models in the training and test groups. A value <0.05 on both sides was considered statistically significant.
+ Open protocol
+ Expand
7

COVID-19 and Mycoplasma pneumoniae Prevalence

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data are presented as median values and interquartile ranges (IQRs) for continuous variables and frequencies and percentages for categorical variables. Continuous-variable comparisons between the groups were performed using the Mann-Whitney U test. Categorical variables were compared using the Fisher exact test. Pearson correlation coefficients were examined to assess whether the prevalence of COVID-19 was associated with the prevalence of M. pneumoniae. Statistical significance was determined as a 2-sided P value of <0.05. Statistical analyses were performed using SPSS software 25.0 (IBM SPSS Statistics, Armonk, NY, USA).
+ Open protocol
+ Expand
8

Craniocervical Atherosclerosis and Poststroke Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chi‒square test or Fisher’s exact test was used in the comparisons of categorical variables. The Shapiro‒Wilk test was used to test the data distribution. Normally distributed continuous variables are described by the mean ± standard deviation (SD), and nonnormally distributed continuous variables are described by the median (interquartile range, IQR). Student’s t test or Mann‒Whitney U test was used in the comparisons of continuous variables between 2 groups, whereas the one-way analysis of variance test or Kruskal‒Wallis test was used in the comparisons of continuous variables among 3 groups, if appropriate.
After the univariable analysis, age, sex and clinical factors with a p value < 0.1 were included in the multivariable modified Poisson regression analysis30 (link) to determine the relationships of craniocervical AS number and poststroke inflammatory markers with 90-day poor functional outcome. Subsequently, all participants were categorized into 3 groups based on the tertiles of the craniocervical AS number. Multivariable ordinal logistic regression analysis was used to determine the relationship of the poststroke inflammatory markers with the craniocervical AS number. All statistical analyses were performed by using SPSS software 25.0 (IBM, Armonk, NY, United States). All tests were two-sided, and a p value < 0.05 was considered statistically significant.
+ Open protocol
+ Expand
9

Nutrition-Related Prognostic Indicators in Older ESCC Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were conducted using IBM SPSS software 25.0 and R software 4.0.2. We turned all continuous variables into classified variables according to the optimal cut-off value of the Receiver Operating Curve (ROC). Using the Chi-square test or Fish’s exact test, the difference between the classified data was evaluated. OS and PFS were plotted using the Kaplan–Meier curves and compared using the log-rank test. The univariate and multivariate Cox analyses were performed to evaluate the association between pre-treatment nutrition-related indicators and prognosis in older patients with locally advanced ESCC. In univariate analyses, all variables with a p value < 0.10 were incorporated into multivariate analyses. Using the time-dependent ROC (time-ROC) and C-index, the predictive ability of each independently nutrition-related prognostic indicator was evaluated. In addition, the relationship between nutrition-related indicators and survival outcomes was assessed using the Restricted Cubic Splines (RCS). To understand the application of the same prognostic indicators in different subgroups, we performed a subgroup analysis of age, sex, radiation dose, chemotherapy, tumor location, tumor length, T stage, N stage, tumor stage, and PNI. Statistically, a p value < 0.05 was considered significant.
+ Open protocol
+ Expand
10

Circular RNA Biomarker for CRC Prognosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data were expressed as percentages of the total and means ± SD. Each independent experiment was repeated 3 times and average values were calculated. Any differences in plasma hsa_circ_0002320 levels between patients with CRC and healthy controls were detected using a t test.
The Pearson χ2 test was used to explore associations between clinicopathological features and survival time. The Spearman rho test was used to compare characteristics and survival times for the correlation analysis. If any analytic results reached a liberal statistical threshold of P < .2 for each comparison, the risk factors were forced into a multivariable linear regression model to confirm independent risk factors for the survival time. Univariate and multivariate Cox regression analysis was used to calculate the hazard ratio (HR) of each characteristic for overall survival (OS). Finally, we used the Kaplan–Meier method to explore OS. A receiver-operating characteristic (ROC) curve analysis was performed to determine the ability of CEA and hsa_circ_0002320 to predict prognoses in patients with CRC.
All data analysis was conducted using SPSS software 25.0 (IBM, Armonk, NY) and GraphPad Prism software 8.0 (GraphPad Prism Software Inc, San Diego, CA). A P value <0.05 was considered statistically significant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!